Shanghai Pharmaceuticals Holding Co. Ltd.SSE: 601607

Indicative Announcement on Changes in Shareholder's Equity

Sep 23, 2025 · Issued by Shanghai Pharmaceuticals Holding Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Sep 23, 2025

On 6ix: 6ix.com/news/indicative-announcement-on-changes-in-shareholders-equity-84

Indicative Announcement on Changes in Shareholder's Equity

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Shanghai Pharmaceuticals Holding Co. Ltd. on 6ix

Earlier from Shanghai Pharmaceuticals

Announcement on Nicorandil Tablet Passing Generic Drug Consistency EvaluationSep 19, 2025
Announcement on Shareholding Increase Plan for the Controlling ShareholderSep 16, 2025
Announcement on Obtaining Philippine Drug Registration Certificate for Aripiprazole TabletsSep 13, 2025
Announcement on Diprophylline Injection Passing Generic Drug Consistency EvaluationSep 5, 2025
Announcement on Verapamil Hydrochloride Injection Passing Generic Drug Consistency EvaluationSep 2, 2025

Later from Shanghai Pharmaceuticals

Announcement on Resignation of Senior Management MembersSep 26, 2025
Announcement on Independent Exercise Results of Reserved Stock Options in the 3rd Vesting Period of 2019 A-share Stock Option Incentive Plan and in Q3 2025Oct 10, 2025
Announcement on Obtainment of U.S. FDA Approval for Doxycycline CapsulesOct 15, 2025
Announcement on the Subsidiary Becoming the Marketing Authorization Holder of Amisulpride Orally Disintegrating TabletsOct 25, 2025
Announcement on Convening the Q3 2025 Performance BriefingOct 29, 2025

All Shanghai Pharmaceuticals news releases

Follow Shanghai Pharmaceuticals into a list and get an email when it puts out news.

Follow Shanghai Pharmaceuticals